MedTrace Logo

Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis

NCT07784712 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-08-25

No results posted yet for this study

Summary

People eligible for this study have had the suggestion from their doctor to receive a cardiac pacemaker or defibrillator to treat a cardiac condition as part of their routine care. We are doing this study to understand if obtaining a tissue sample from their body during a device implant may assist in the early diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CM).

Conditions

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Pugazhendhi Vijayaraman, MD · Geisinger Clinic

Eligibility

Min Age
50 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2028-04-30
Completion
2028-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07784712 on ClinicalTrials.gov